PolySciTech Products In Literature
PLGA-PEG-folate from PolySciTech used in development of kidney-targeting nanoparticles to treat hypertension
High blood pressure is a common medical problem that is exacerbated by inflammation in the lymph system and kidneys which prevents the screening out and removal of excess sodium and waste products from the body. Left untreated, hypertension can lead to an increased risk of heart attack, stroke, or other severe medical problems. Recently, researchers at Texas A&M University used PLGA-PEG-folate (AI168) from PolySciTech to develop kidney-targeting nanoparticles that reduce inflammation and can lead to improved sodium excretion. This research holds promise to improve therapeutic outcomes for a variety of diseases related to hypertension. Read more: Goodlett, B.L., Kang, C.S., Yoo, E., Navaneethabalakrishnan, S., Balasubbramanian, D., Love, S.E., Sims, B.M., Avilez, D.L., Tate, W., Chavez, D.R. and Baranwal, G., 2022. A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice. Pharmaceutics, 14(1), p.84.
|
|
Print what you want with the latest bioresorbable polymer technology. AKiNAfil™ bioresorbable PLGA polymers reformatted in standardized 1.7 mm filament are available in a variety of lengths. The PLGA polymers are co-formulated with FDA-GRAS and biocompatible acetyltriethylcitrate (ATEC) plasticizer for improved processability and biorelevant degradation properties to be used in a wide array of biomedical applications. |
|
|
Browse through our searchable list of research
that reference the use of PolySciTech products.
|
|
|
PolySciTech Division of Akina, Inc. (www.polyscitech.com) provides a wide array of biodegradable polymers and other research supplies. Visit our website to find out more.
|
|
|
|
